Bruker Corp (BRKR) stock analysis

P/E against its history

Not enough price and earnings history to compare.

P/E against the industry

Needs positive earnings and enough profitable companies in the industry.

EV/EBITDA above its 5-year median

Bruker's EV/EBITDA of 71.0 is above its 5-year median of 21.2.

P/S below the industry

Bruker's price-to-sales of 2.76 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.99 (book value is negative, so we use sales).

Trading above fair value

The share price of $62.41 is above our fair value estimate of $11.55.

Margin of safety under 20%

The price is 440% above fair value, so there is no margin of safety.

Revenue growing 10%+ a year

Revenue grew 10.7% a year over the last three fiscal years.

EPS growth over 3 years

Needs positive EPS three years ago and today.

Earnings acceleration

Needs positive net income now, a year ago and five years ago.

Growing slower than the industry

Revenue grew 2.2% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.

Guidance lowered

Bruker lowered its FY2026 Revenues outlook on Aug 4, 2026.

Gross margin improving

Gross margin was 47.7% over the last twelve months, against 47.2% a year earlier.

Return on equity under 15%

Return on equity was -5.1% over the last twelve months and averaged 19.1% over five years; we look for 15% on both.

Return on capital under 10%

Return on invested capital was -1.3%, below the 10% that usually covers the cost of capital.

Return on equity below the industry

Bruker's return on equity of -5.1% is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.

Earnings over 5 years

Needs positive net income five years ago and in the latest year.

Net margin below its 5-year average

Net margin was -3.5% over the last twelve months, against a 5-year average of 8.1%.

Net margin below the industry

Bruker's net margin of -3.5% is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.

Debt level

Needs debt and equity figures.

Debt trend

Needs a balance sheet from five years ago with positive equity.

Debt not well covered by cash flow

Operating cash flow over the last twelve months equals 19.9% of total debt; we look for at least 20%.

Interest not well covered

Operating income covers interest expense -1.2 times; we look for at least 5.

Short-term assets cover short-term debts

Current assets are 1.84 times current liabilities.

Bankruptcy risk in the grey zone

The Altman Z-score is 2.42; above 3 is the safe zone and below 1.8 the distress zone.

Pays a dividend

Bruker paid dividends worth 0.3% of the share price over the last twelve months.

Yield below Treasuries

The 0.3% yield is below the 4.4% on a 1-year Treasury.

Yield below the top quarter

The top quarter of US dividend payers yield 3.8% or more; Bruker yields 0.3%.

Dividend not cut

The dividend per share has not fallen by more than 10% in any of the last 9 fiscal years.

Earnings cover

Needs dividends paid and net income.

Covered by free cash flow

Dividends take 12.4% of free cash flow.